Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-23

FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Risperidone submitted by Janssen Pharmaceutical, Inc. The action pertains to an addition or modification to the drug…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)